Episode details
Available for over a year
UK and Russian scientists are teaming up to trial a combination of the Oxford-AstraZeneca and Sputnik V vaccines to see if protection against Covid-19 can be improved. Mixing two similar vaccines could lead to a better immune response in people. The trials, to be held in Russia, will involve over-18s, although it's not clear how many people will be involved. The British-made Oxford vaccine, developed in partnership with AstraZeneca, and the Russian Sputnik vaccine, developed by the Gamaleya Research Institute in Moscow, are similar because they both contain genetic material from the Sars-CoV-2 spike protein. The 麻豆社's Julian Marshall has been speaking to Kirill Dimitriev from the Russian Direct Investment Fund, which put up the money for the development of Sputnik V. Photo shows: A medical worker fills a syringe with Sputnik V (Gam-COVID-Vac) vaccine at a clinic in the town of Domodedovo near Moscow. Credit: Reuters
Programme Website